Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease

• Anna Alisi ,

  * E-mail: anna.alisi@opbg.net

  Affiliation Hepato-Metabolic Disease Unit and Liver Research Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Sara Ceccarelli,

  Affiliation Hepato-Metabolic Disease Unit and Liver Research Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Nadia Panera,

  Affiliation Hepato-Metabolic Disease Unit and Liver Research Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Federica Prono,

  Affiliation Hepato-Metabolic Disease Unit and Liver Research Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Stefania Petrini,

  Affiliation Microscopy Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Cristiano De Stefanis,

  Affiliation Hepato-Metabolic Disease Unit and Liver Research Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Marco Pezzullo,

  Affiliation Core Facilities, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Alberto Tozzi,

  Affiliation Epidemiology Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Alberto Villani,

  Affiliation Pediatrics and Infectious Disease Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯
• Giorgio Bedogni,

  Affiliation Clinical Epidemiology Unit, Liver Research Center, Trieste, Italy

  ⨯
• Valerio Nobili

  Affiliation Hepato-Metabolic Disease Unit and Liver Research Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

  ⨯